Xcout IntelASTRA Therapeutics
ASTRA Therapeutics is a biotechnology and drug design company focused on animal health and anti-parasitic drug discovery. Located at the Swiss Innovation Park Innovaare in Villigen, Switzerland, the company leverages atomic resolution to craft next-generation small-molecule treatments against parasitic diseases.
Subscribe to see ASTRA Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ASTRA Therapeutics at a glance
ASTRA Therapeutics is a life sciences company headquartered in Switzerland. Its most recent funding round, Seed, raised $9.7M in July 2025. Xcout tracks 4 named people at ASTRA Therapeutics, including Marshall Ungar (CFO).
ASTRA Therapeutics leadership
- Marshall UngarCFO
- Ashwani SharmaCo-Founder & Co-CEO
- Natacha GaillardCo-Founder & Co-CEO
- Fabian KauscheChairman
ASTRA Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $9.7M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ASTRA Therapeutics competitors
A few of ASTRA Therapeutics's closest competitors — see the full list of competitors and alternatives →
Antigenesis is a biotechnology company specializing in antibody discovery and antigen design, pioneering the application of human-grade therapeutic innovations to veterinary medicine and companion animals.
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
RayThera is a small molecule drug discovery company founded in August 2023, headquartered in San Diego, CA, United States. Its mission is to develop safer, more effective therapeutics by advancing drug discovery with proven expertise and adaptable approaches. The company focuses on transformative therapies for unmet medical needs.
Okapi Sciences was a Belgian biotechnology company focused on discovering and developing antiviral medicines, particularly for veterinary applications and companion animals. It served the animal-health pharmaceutical market by developing treatments for viral diseases.
Atavistik Bio is a U.S. biotechnology company developing small-molecule medicines by targeting allosteric sites and metabolite-regulated biology, using its chemoproteomics and drug-discovery platform. Its programs are aimed at treating cancer and other serious diseases.
Qubit Pharmaceuticals is a privately held company headquartered in Paris, France, that brings precision to drug discovery and design by utilizing cutting-edge quantum physics-based science to develop life-changing treatments.
Get ASTRA Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ASTRA Therapeutics in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access